Statistics for Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes
Total visits
| views | |
|---|---|
| Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes | 4 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:3b33e741-34c0-47a1-b65a-8af6e578d4c6 | 39 |
| java.util.UUID:e448cc27-623d-4c13-a844-59ca29679e25 | 15 |
| Freedman2022Low-AAM.pdf | 12 |
| java.util.UUID:953e1988-785f-4c89-bbfb-4de9943a8ada | 5 |
Top country views
| views | |
|---|---|
| United States | 4 |
Top city views
| views | |
|---|---|
| Indianapolis | 4 |